| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/02/2007 | US20070178086 Monoclonal antibody against ABCA1 |
| 08/02/2007 | US20070178085 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070178083 Medicinal compositions containing Fc receptor gamma-chain activator |
| 08/02/2007 | US20070178082 Stabilized single domain antibodies |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | US20070178065 Neutralizing factors as vaccine adjuvants |
| 08/02/2007 | US20070178063 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 08/02/2007 | US20070177118 Dynamic fluid control system for immersion lithography |
| 08/02/2007 | DE102006003782A1 Treatment and prevention of autoimmune diseases, e.g. hemolytic anemia or arteriosclerosis, by extracorporeal adsorption of autoantibodies on to specific autoantigens |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2640066A1 Fusion proteins that contain natural junctions |
| 08/02/2007 | CA2638799A1 Cd86 and cd80 receptor competition assays |
| 08/02/2007 | CA2637945A1 Binding molecules |
| 08/02/2007 | CA2637929A1 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 08/02/2007 | CA2637463A1 Synergistic compositions for treating hiv |
| 08/02/2007 | CA2637156A1 Methods for modulating mannose content of recombinant proteins |
| 08/02/2007 | CA2636854A1 Ligands that bind il-4 and/or il-13 |
| 08/01/2007 | EP1813672A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 08/01/2007 | EP1813668A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/01/2007 | EP1812578A2 Suppression of endogenous immunoglobulin expression in non-human transgenic animals |
| 08/01/2007 | EP1812476A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 08/01/2007 | EP1812475A2 Immunoglobulin fractions |
| 08/01/2007 | EP1812465A1 Novel composition and methods for the treatment of immune related diseases |
| 08/01/2007 | EP1812410A2 Indinavir derivatives useful in immunoassay |
| 08/01/2007 | EP1812068A2 Methods of preventing and treating rsv infections and related conditions |
| 08/01/2007 | EP1812063A2 Monoclonal antibodies to the propeptide of candida albicans and methods of use |
| 08/01/2007 | EP1812062A2 Anti-addl antibodies and uses thereof |
| 08/01/2007 | EP1812060A2 Method for treating vasculitis |
| 08/01/2007 | EP1812058A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 08/01/2007 | EP1812055A1 Chlamydia antigens and uses thereof |
| 08/01/2007 | EP1812050A1 Composition comprising vlp and amyloid-beta peptide |
| 08/01/2007 | EP1812046A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 08/01/2007 | EP1811832A2 Ungulates with genetically modified immune systems |
| 08/01/2007 | EP1687402A4 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/01/2007 | EP1539221A4 Transferrin fusion protein libraries |
| 08/01/2007 | EP1344821B1 Novel aggrecanase |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1214339B1 Polypeptides from moraxella (branhamella) catarrhalis |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | EP0948344B1 Synthetic antibiotics |
| 08/01/2007 | EP0929310B1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies |
| 08/01/2007 | CN1329732C Use of human RGPR protein in preparing prostatic cancer diagnostic reagent kit |
| 08/01/2007 | CN1329413C Antibody for treating or preventing senile dementia, its expression vector and application in drug preparation |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN101010427A Anti-A33 antibody |
| 08/01/2007 | CN101010342A Compositions and methods for treatment of non-hodgkin's lymphoma |
| 08/01/2007 | CN101010100A Treatment of cancer |
| 08/01/2007 | CN101010097A Hai-1 and hai-2 in cancer therapy |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007849A Low molecule agonist antibodies |
| 08/01/2007 | CN101007845A Method for screening high egg-yield fowl |
| 07/31/2007 | US7250505 Polynucleotide that encodes the Drosophila murine Dab 1 (Disabled protein 1); improve the development of the nervous system; protein phosphotyrosine levels; Antibodies for drug screening and diagnostic methods |
| 07/31/2007 | US7250501 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein |
| 07/31/2007 | US7250494 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 07/31/2007 | US7250493 FC fusion proteins of human erythropoietin with increased biological activities |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250491 Hemolytic active proteins and genes encoding the same |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250282 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250276 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 07/31/2007 | US7250264 Administering to host a therapeutically effective amount of an agent which prevents the interaction of mucosal addressin cell adhesion molecule-1 with a ligand therefor |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250167 Monoclonal antibody for use in increasing kidney allograft suvival and as immunosuppressant; prevention of graft versus host disease |
| 07/31/2007 | US7250166 human monoclonal antibodies against hepatiti c E1 antigen, reagent with such antibodies, vaccine; treating or preventing HCV infection by administration of the vaccine composition |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250164 Vaccine composition for preventing meningococcal disease |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2239596C Sugar-chain-recognizing antibodies and remedies for hiv infectious diseases |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007084740A2 Tat-030 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084708A2 Tat-028 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084693A2 Immunoconjugates with improved efficacy for the treatment of diseases |
| 07/26/2007 | WO2007084672A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
| 07/26/2007 | WO2007084599A2 Methods of increasing lymphatic function |
| 07/26/2007 | WO2007084388A2 Nogo-b receptor |
| 07/26/2007 | WO2007084321A2 Antibodies to ox-2/cd200 and uses thereof |
| 07/26/2007 | WO2007084253A2 High affinity antibodies against hmgb1 and methods of use thereof |
| 07/26/2007 | WO2007084181A2 Bispecific single chain fv antibody molecules and methods of use thereof |
| 07/26/2007 | WO2007084107A2 Monoclonal antibodies that neutralize anthrax protective antigen (pa) toxin |
| 07/26/2007 | WO2007084053A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) |
| 07/26/2007 | WO2007084001A2 Means and methods for modulating stem cell mobilization |
| 07/26/2007 | WO2007083523A1 Method for measuring cholesterol in remnant-like lipoprotein |
| 07/26/2007 | WO2007082777A1 C-terminal exon 5.4 of runx1/aml1 |
| 07/26/2007 | WO2007082750A1 IMMUNOGLOBULIN-BOUND Aβ-PEPTIDES AND IMMUNOGLOBULINS-BINDING Aβ- PEPTIDES IN DIAGNOSIS AND THERAPY OF ALZHEIMER'S DEMENTIA |
| 07/26/2007 | WO2007082715A2 Anti-cd19 antibody composition and method |
| 07/26/2007 | WO2007067992A9 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 |
| 07/26/2007 | WO2007062852A3 ANTI-Aβ GLOBULOMER ANTIBODIES, ANTIGEN-BINDING MOIETIES THEREOF, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCING SAID ANTIBODIES, COMPOSITIONS COMPRISING SAID ANTIBODIES, USES OF SAID ANTIBODIES AND METHODS OF USING SAID ANTIBODIES |